This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
US Specialty Chemical Rebound Continues as August Volume Rises
by Anindya Barman
U.S. specialty chemicals market volumes ticked up 0.5% in August with most segments seeing growth.
Earnings Preview: H. B. Fuller (FUL) Q3 Earnings Expected to Decline
by Zacks Equity Research
H. B. Fuller (FUL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FUL vs. ECL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FUL vs. ECL: Which Stock Is the Better Value Option?
Global Chemical Output Up As Activity Picks Up in Key Regions
by Anindya Barman
Global chemical production rose 1.4% in July on gains across all chemical industry segments.
FUL vs. ECL: Which Stock Is the Better Value Option?
by Zacks Equity Research
FUL vs. ECL: Which Stock Is the Better Value Option?
US Specialty Chemical Volumes Expand in July: 4 Top Picks
by Anindya Barman
The rebound in manufacturing activity and continued recovery in the U.S. economy are likely to act as a tailwind for the U.S. specialty chemical industry.
Should Value Investors Buy H. B. Fuller (FUL) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FUL vs. ECL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FUL vs. ECL: Which Stock Is the Better Value Option?
Chemical Specialty Industry Outlook Bleak on Muted Demand
by Anindya Barman
Weak demand and raw material supply disruptions due to coronavirus pose as headwinds to the chemical specialty industry.
FUL vs. COIHY: Which Stock Is the Better Value Option?
by Zacks Equity Research
FUL vs. COIHY: Which Stock Is the Better Value Option?